Entecavir monohydrate is a guanosine nucleoside analogue indicated for the treatment of chronic hepatitis B infection. By inhibiting viral DNA polymerase, this antiviral agent prevents viral replication… Read more
Entecavir monohydrate is a guanosine nucleoside analogue indicated for the treatment of chronic hepatitis B infection. By inhibiting viral DNA polymerase, this antiviral agent prevents viral replication within infected hepatocytes. To support rigorous quality control and method validation in pharmaceutical laboratories, this category provides a selection of Entecavir monohydrate reference standards. This collection includes critical impurities, such as stereoisomers and hydroxy derivatives, alongside stable isotope labelled compounds essential for precise quantification. These materials are vital for accurate impurity profiling and analytical testing throughout the drug development lifecycle. By utilizing these compounds, researchers and analysts can ensure compliance with regulatory requirements and maintain the consistency of the active pharmaceutical ingredient during stability testing and routine analytical assays.